Medtronic PLC

Common Name
Medtronic
Country
Ireland
Sector
Healthcare
Industry
Medical Devices
Employees
95,000
Ticker
MDT
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Medtronic plc is a leading global healthcare technology company that designs, manufactures, and sells innovative medical devices and therapies used in various medical procedures. The primary function ...

Medtronic's GHG Emissions Data Preview

In 2024, Medtronic completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).

Medtronic has also provided a category-level breakdown for 12 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Medtronic's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Medtronic amounted to 359,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Medtronic decreased by 4.01%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

Medtronic's Scope 1 Emissions Over Time

201920202021202220232024040 k80 k120 k160 ktCO2e+148%-6%+6%+1%-4%
  • Total Scope 1
  • Year-over-Year Change

What are Medtronic's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Medtronic were 150,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Has Medtronic reduced its Scope 1 emissions over time?

Since 2019, Medtronic's Scope 1 emissions have increased by 138.47%, reflecting a rising long-term trend in Scope 1 emissions over time.

Compared to the previous year (2023), Medtronic's Scope 1 emissions decreased by 4.46%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are Medtronic's Scope 2 emissions?

In 2024, Medtronic reported Scope 2 greenhouse gas (GHG) emissions of 118,000 tCOâ‚‚e using the market-based method, and 209,000 tCOâ‚‚e using the location-based method.

Has Medtronic reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Medtronic's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Medtronic 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does Medtronic use for Scope 2 reporting?

In 2024, Medtronic reported its Scope 2 emissions using the market-based method and using the location-based method.

Medtronic's Scope 2 Emissions Over Time

201920202021202220232024060 k120 k180 k240 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Medtronic's Value Chain Emissions

In 2024, Medtronic reported 3,213,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.

The 2024 disclosure of Medtronic includes a breakdown across 12 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.

Medtronic's Scope 3 Emissions Over Time

202320240900 k1.8 M2.7 M3.6 MtCO2e-11%
  • Total Scope 3
  • Year-over-Year Change

What are Medtronic's Scope 3 emissions?

In 2024, Medtronic reported total Scope 3 emissions of 3,213,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Approximately 78.99% of these emissions originated from upstream activities such as purchased goods and capital goods, while 21.01% came from downstream activities like product use, distribution, and end-of-life treatment.

Compared to the previous year (2023), Medtronic's Scope 3 emissions decreased by 10.6%, highlighting the company's efforts to lower indirect emissions from its value chain.

What categories of Scope 3 emissions does Medtronic disclose?

In 2024, Medtronic reported emissions for 12 out of the 15 Scope 3 categories defined by the GHG Protocol.

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Medtronic's Scope 3 emissions?

In 2024, the largest contributors to Medtronic's Scope 3 emissions were:

  • Purchased Goods and Services (Cat. 1): 1,706,000 tCOâ‚‚e (53.1%)
  • Upstream Transportation and Distribution (Cat. 4): 326,000 tCOâ‚‚e (10.15%)
  • End-of-Life Treatment of Sold Products (Cat. 12): 315,000 tCOâ‚‚e (9.8%)

Medtronic's Scope 3 Emissions by Categories

End-of-LifeTreatment of SoldProducts (Cat. 12)(9.8%)UpstreamTransportation andDistribution(Cat. 4)(10.1%)Purchased Goods andServices (Cat. 1)(53.1%)

Insights into Medtronic's Total Carbon Footprint

In 2024, Medtronic reported a total carbon footprint of 3,572,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 9.98% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.

The largest contributor to Medtronic's total carbon footprint was Scope 3 emissions, accounting for 89.95% of the company's total carbon footprint, followed by Scope 2 emissions at 5.85%.

Want Full Access to Medtronic's GHG Emissions Dataset?
Sign Up